BOOSTRIX-POLIO
Google image searchProduct monograph
Active ingredients
diphtheria toxoid adsorbed, 2.5 LF/0.5 ML
tetanus toxoid adsorbed, 5.0 LF/0.5 ML
pertussis toxoid adsorbed, 8 MCG/0.5 ML
filamentous haemagglutinin adsorbed, 8 MCG/0.5 ML
pertactin adsorbed, 2.5 MCG/0.5 ML
inactivated poliovirus type i, 40 D/0.5 ML
inactivated poliovirus type ii, 8 D/0.5 ML
inactivated poliovirus type iii, 32 D/0.5 ML
DIN: 02312557
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAMUSCULAR
Schedule: Schedule D
Company: GLAXOSMITHKLINE INC
Date: 22-OCT-2010
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07C — BACTERIAL AND VIRAL VACCINES, COMBINED (ATC, ATC/DDD)
- J07CA — Bacterial and viral vaccines, combined (ATC, ATC/DDD)
- J07CA02 — DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS (ATC/DDD)
External Links for Boostrix-Polio
Search on Google
- Boostrix-Polio side effects
- Boostrix-Polio dosage
- diphtheria toxoid adsorbed side effects
- diphtheria toxoid adsorbed dosage
- tetanus toxoid adsorbed side effects
- tetanus toxoid adsorbed dosage
- pertussis toxoid adsorbed side effects
- pertussis toxoid adsorbed dosage
- filamentous haemagglutinin adsorbed side effects
- filamentous haemagglutinin adsorbed dosage
- pertactin adsorbed side effects
- pertactin adsorbed dosage
- inactivated poliovirus type i side effects
- inactivated poliovirus type i dosage
- inactivated poliovirus type ii side effects
- inactivated poliovirus type ii dosage
- inactivated poliovirus type iii side effects
- inactivated poliovirus type iii dosage
Glaxosmithkline Inc
Go to GlaxoSmithKline website to see drug product details. Sometimes you can find boostrix-polio photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.
